Novel Inhibitors of HIV Discovered Among Existing Classes of Pharmaceutical Compounds Indicated for Unrelated Clinical Indications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|11|1187-1190

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.11, 2009-04, pp. : 1187-1190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel integrase inhibitors for HIV

By Prada Nicole Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1087-1098

Informa Healthcare

Access to resources Recommend Favorite

Correlations between Factors Determining the Pharmacokinetics and Antiviral Activity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors of the Diaryltriazine and Diarylpyrimidine Classes of Compounds

By Paul Lewi

Drugs in R&D, Vol. 5, Iss. 5, 2004-01 ,pp. : 245-257

Adis International

Access to resources Recommend Favorite

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

By Buckheit Robert W

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1423-1442

Informa Healthcare

Access to resources Recommend Favorite

Novel Inhibitors of HIV-1 Integration

Current Drug Metabolism, Vol. 5, Iss. 4, 2004-08 ,pp. : 291-304

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Integrase Inhibitors: An Emerging Clinical Reality

By Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 155-168

Adis International

Access to resources Recommend Favorite